Product Images Tadalafil
View Photos of Packaging, Labels & Appearance
- Tadalafil Tab 5mg - 20mg dahej 30s
- Structural formula - 30ee4705 36a5 4a56 852d 9d76c40668db 01
- Figure 1 - 30ee4705 36a5 4a56 852d 9d76c40668db 02
- Figure 2 - 30ee4705 36a5 4a56 852d 9d76c40668db 03
- Figure 3 - 30ee4705 36a5 4a56 852d 9d76c40668db 04
- Figure 4 - 30ee4705 36a5 4a56 852d 9d76c40668db 05
- Figure 5 - 30ee4705 36a5 4a56 852d 9d76c40668db 06
- Figure 6 - 30ee4705 36a5 4a56 852d 9d76c40668db 07
- Figure 7 - 30ee4705 36a5 4a56 852d 9d76c40668db 08
- Figure 8 - 30ee4705 36a5 4a56 852d 9d76c40668db 09
- Torrent Logo - 30ee4705 36a5 4a56 852d 9d76c40668db 10
- Torrent Logo-PI - 30ee4705 36a5 4a56 852d 9d76c40668db 11
Product Label Images
The following 12 images provide visual information about the product associated with Tadalafil NDC 68788-4018 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 2 - 30ee4705 36a5 4a56 852d 9d76c40668db 03

This data appears to be related to a study or evaluation involving standing and supine systolic blood pressure (BP) measurements over time after the administration of Tadalafil 20 mg & doxazosin 8 mg and Placebo & doxazosin 8 mg. The chart shows the variation in systolic BP in mmHg over 24 hours post-dose. The study seems to compare the effects of different medication combinations on blood pressure.*
Figure 4 - 30ee4705 36a5 4a56 852d 9d76c40668db 05

This is a data table showing plasma Tadalafil concentrations in ug/L at different time intervals after taking a single 20-mg Tadalafil dose, a single 5-mg Tadalafil dose, and a once-daily 5-mg Tadalafil dose following 5 consecutive days of administration. The time intervals include measurements at 0, 12, 24, 36, 48, 60, 72, 84, 96, 108, and 120 hours.*
Figure 5 - 30ee4705 36a5 4a56 852d 9d76c40668db 06

Change from Baseline in IPSS Total Score compared between Tadalafil 5 mg and Placebo group over a 12-week treatment period.*
Figure 6 - 30ee4705 36a5 4a56 852d 9d76c40668db 07

Change from Baseline in IPSS Total Score comparing Tadalafil 5 mg with Placebo over a period of 4, 8, and 12 weeks of treatment. The statistical significance of the results is denoted by *p<0.001.*
Figure 7 - 30ee4705 36a5 4a56 852d 9d76c40668db 08

This text appears to be showing the LS Mean Change from Baseline for a study comparing Tadalafil/Finasteride and Placebo/Finasteride at 12 and 26 weeks of therapy. The data also includes p-values for the comparison.*
Figure 8 - 30ee4705 36a5 4a56 852d 9d76c40668db 09

This text provides information on the change from baseline in IPSS Total Score comparing Tadalafil 5mg to Placebo over a 12-week treatment duration. The result indicates a statistically significant difference between the two groups with p<0.01, suggesting that Tadalafil 5mg had a positive impact on the IPSS Total Score compared to Placebo.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.